CYSTADANE® (betaine anhydrous for oral solution) drug shortage has been resolved 03/05/2018 RECORDATI RARE DISEASES PARTNERS WITH THE NATIONAL UREA CYCLE DISORDERS FOUNDATION TO INCREASE AWARENESS OF THE RISKS OF HYPERAMMONEMIA 11/29/2017 European Press Release From Recordati SpA: RECORDATI LICENSES AN INNOVATIVE TREATMENT FOR NEUROTROPHIC KERATITIS 06/19/2017 Pagination First page « First Previous page ‹ Previous … Page 11 Page 12 Current page 13 Page 14 Next page Next › Last page Last »
RECORDATI RARE DISEASES PARTNERS WITH THE NATIONAL UREA CYCLE DISORDERS FOUNDATION TO INCREASE AWARENESS OF THE RISKS OF HYPERAMMONEMIA 11/29/2017
European Press Release From Recordati SpA: RECORDATI LICENSES AN INNOVATIVE TREATMENT FOR NEUROTROPHIC KERATITIS 06/19/2017